<DOC>
	<DOCNO>NCT01116752</DOCNO>
	<brief_summary>The primary goal project determine whether normalize hyperglycemia safe approach improve multisystem organ function critically ill child require intensive care . The conduct `` PedETrol '' ( `` Pediatric ICUs Emory-Children 's Center Glycemic Control : The PedETrol Trial ) Trial , 4-year single-center , prospective , randomized clinical trial evaluate outcome benefit , safety resource utilization impact maintain strict glucose control child life-threatening condition . ***This study support Research Project Grant ( RO1 grant ) ( MRR ) via National Heart , Lung , Blood Institute ( NHLBI ) .</brief_summary>
	<brief_title>Pediatric Intensive Care Units ( ICUs ) Emory-Children 's Center Glycemic Control : The PedETrol Trial</brief_title>
	<detailed_description>Many report demonstrate improve outcome critically ill adult develop hyperglycemia rigorous glycemic . Medical oversight committee ( include Institutes Healthcare Improvement , American Diabetes Association , Society Critical Care Medicine , among others ) recommend routine glycemic control critical illness . Some study show high rate hypoglycemia highlight concern approach care . Little data exists hyperglycemia glycemic control affect critically ill child . Our practice group develop regular approach glycemic control appear effective safe control hyperglycemia investigator believe due unique experience expertise field , investigator well-poised conduct much need study regard glycemic control child . To specifically address void knowledge regard glycemic control critically ill child , investigator conduct single-center randomized control trial ascertain whether vital organ system , outcome , resource utilization benefit strict glycemic control vs. conservative control child require intensive care . The `` PedETrol '' ( `` Pediatric ICUs Emory-Children 's Center Glycemic Control ) Trial study 1,004 child admit ICU medical , surgical , cardiac condition require mechanical ventilation and/or vasopressor/i support develop hyperglycemia , define persistent blood glucose &gt; 140 mg/dL ) . Participants randomize either receive strict glycemic control ( 80-140 mg/dL ) conservative control ( 190-220 mg/dL ) . Insulin infusion use maintain blood glucose range . In addition assess organ outcome specific efficacy parameter , investigator meticulously evaluate untoward effect include hypoglycemia , determine impact practice costly medical resource . All child &lt; 1 year old 25 % &gt; 1 year old , able receive continuous glucose monitoring via interstitial glucometry . This appear first glycemic control trial critical care population make use continuous glucose monitoring .</detailed_description>
	<mesh_term>Hyperglycemia</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Critically ill child hyperglycemia , define persistent BG &gt; 140 mg/dL , meet follow criterion target study . Age 1 month 18 year old Admission pediatric medical/surgical pediatric cardiac intensive care unit Require mechanical ventilation and/or vasopressors/inotropic infusion Patient family member available discus inform consent criterion provide inform consent . Age &gt; 18 year old Age &lt; 1 month chronologic age Patients type I diabetes mellitus condition impair glycogen store counter regulatory response ( i.e . inborn error metabolism , fulminant hepatic failure ) Patients `` resuscitate '' , `` intubate '' , `` escalate care '' order Lack availability parent legal guardian assist consent process exclude</criteria>
	<gender>All</gender>
	<minimum_age>1 Month</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Intensive Care</keyword>
	<keyword>Critical care</keyword>
	<keyword>Glycemic Control</keyword>
	<keyword>Hypoglycemia</keyword>
	<keyword>Hyperglycemia</keyword>
	<keyword>Insulin treatment</keyword>
	<keyword>Organ Function</keyword>
	<keyword>PELOD</keyword>
	<keyword>Outcomes</keyword>
	<keyword>Pediatrics</keyword>
</DOC>